Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase

被引:84
|
作者
Burke, DH
Scates, L
Andrews, K
Gold, L
机构
[1] UNIV COLORADO, DEPT MOL CELLULAR & DEV BIOL, BOULDER, CO 80309 USA
[2] NEXSTAR PHARMACEUT INC, BOULDER, CO 80301 USA
关键词
reverse transcriptase; RNA-protein interactions; SELEX; RNA pseudoknots; nucleic acid structure;
D O I
10.1006/jmbi.1996.0667
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The reverse transcriptase (RT) of the human immunodeficiency virus (HIV) is a proven target for therapeutic intervention of HIV infections. We have found several new RNA inhibitors of HIV-1 RT that differ significantly from the pseudoknot ligands found previously, along with a wide variety of pseudoknot variants. One pseudoknot variant and three novel ligands were studied in more detail. Each specifically inhibits DNA polymerization by HIV RT (half-maximal inhibition at 0.3 to 20 nM inhibitor), but not that of RTs derived from MMLV or AMV. The minimal binding element of each isolate was determined by deletion analysis and by gel electrophoresis of protein-bound, partially alkaline-hydrolyzed RNA. Truncations of three of the isolates bound nearly as well as (or better than) the parental sequences, while most deletions in the fourth caused substantial disruption of binding. The truncated versions of two isolates were subjected to six rounds of secondary SELEX after resynthesizing them mutagenically. Patterns of conserved and covarying nucleotides yielded structural models consistent with 5' and 3' boundary determinations for these molecules. Among the four isolates studied in detail, the first is confirmed as being a pseudoknot, albeit with substantial structural differences as compared to the canonical pseudoknots identified previously. The second forms a stem-loop structure with additional flanking sequences required for binding. Tentative structural models for the other two isolates are presented. The minimal fully active truncations of each of these four isolates compete with each other and with a classical RNA pseudoknot for binding to HIV RT, suggesting that they all recognize the same or overlapping sites on the protein, in spite of their apparently dissimilar structures. We model their interactions with RT as mimicking the 40 to 45 degree bend in dsDNA co-crystallized with RT. (C) 1996 Academic Press Limited
引用
收藏
页码:650 / 666
页数:17
相关论文
共 50 条
  • [21] HEXAPRENOID HYDROQUINONES, NOVEL INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LOYA, S
    TAL, R
    HIZI, A
    ISSACS, S
    KASHMAN, Y
    LOYA, Y
    JOURNAL OF NATURAL PRODUCTS, 1993, 56 (12): : 2120 - 2125
  • [22] Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors
    Svicher, Valentina
    Sing, Tobias
    Santoro, Maria Mercedes
    Forbici, Federica
    Rodriguez-Barrios, Fatima
    Bertoli, Ada
    Beerenwinkel, Niko
    Bellocchi, Maria Concetta
    Gago, Federigo
    Monforte, Antonella d'Arminio
    Antinori, Andrea
    Lengauer, Thomas
    Ceccherini-Silberstein, Francesca
    Perno, Carlo Federico
    JOURNAL OF VIROLOGY, 2006, 80 (14) : 7186 - 7198
  • [23] Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites
    Brown, AJL
    Precious, HM
    Whitcomb, JM
    Wong, JK
    Quigg, M
    Huang, W
    Daar, ES
    D'Aquila, RT
    Keiser, PH
    Connick, E
    Hellmann, NS
    Petropoulos, CJ
    Richman, DD
    Little, SJ
    JOURNAL OF VIROLOGY, 2000, 74 (22) : 10269 - 10273
  • [24] An overview on HIV-1 reverse transcriptase inhibitors
    Ravichandran, Shalini
    Veerasamy, Ravichandran
    Raman, Saraswathi
    Krishnan, Palamadai Neelakandam
    Agrawal, Ram Kishore
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2008, 3 (04) : 171 - 187
  • [25] Inhibition of Foamy Virus Reverse Transcriptase by Human Immunodeficiency Virus Type 1 RNase H Inhibitors
    Corona, Angela
    Schneider, Anna
    Schweimer, Kristian
    Roesch, Paul
    Woehrl, Birgitta M.
    Tramontano, Enzo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4086 - 4093
  • [26] Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase
    DeStefano, Jeffrey J.
    Nair, Gauri R.
    OLIGONUCLEOTIDES, 2008, 18 (02) : 133 - 143
  • [27] Disubstituted uracils as novel nonnucleoside inhibitors of HIV-1 reverse transcriptase inhibitors
    Valuev-Elliston, V.
    Babkov, D.
    Paramonova, M.
    Ivanov, A.
    Kochetkov, S.
    FEBS JOURNAL, 2013, 280 : 370 - 370
  • [29] Progress of Bis(heteroaryl)piperazines (BHAPs) as Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) against Human Immunodeficiency Virus Type 1 (HIV-1)
    Xu, Hui
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (01) : 62 - 72
  • [30] Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors
    De Feo, Christopher J.
    Weiss, Carol D.
    VIRUSES-BASEL, 2012, 4 (12): : 3859 - 3911